Literature DB >> 31957839

Circ_0005075 stimulates the proliferation and metastasis of glioma via downregulating SIRT1.

D-Z Fang1, W-J Wang, F-Y Li, J Liu, X-B Hui, D Liu, X-D Wang.   

Abstract

OBJECTIVE: The aim of this study was to uncover the potential influence of circ_0005075 on the malignant progression of glioma and the underlying mechanism. PATIENTS AND METHODS: Circ_0005075 level in glioma tissues and cell lines was detected by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR). The relation between circ_0005075 expression and metastasis of glioma patients was analyzed. Prognostic potential of circ_0005075 in glioma was assessed by calculating overall survival (OS) and progression-free survival (PFS). After knockdown or overexpression of circ_0005075, changes in the viability, migration, and wound closure percentage of T98-G and U87 cells were examined, respectively. Subsequently, expression pattern and prognostic value of SIRT1 in glioma patients were determined. Furthermore, the involvement of SIRT1 in glioma progression affected by circ_0005075 was evaluated through rescue experiments.
RESULTS: Circ_0005075 was significantly up-regulated in glioma tissues and cell lines. Meanwhile, its expression level was significantly higher in glioma patients with lymphatic metastasis or distant metastasis when compared with those with negative metastasis. OS and PFS were both remarkably worse in glioma patients with high expression level of circ_0005075. Knockdown of circ_0005075 decreased the viability, migration, and wound closure percentage of T98-G cells. However, overexpression of circ_0005075 in U87 cells yielded the opposite trends. SIRT1 expression level was negatively regulated by circ_0005075 in glioma. QRT-PCR results demonstrated that SIRT1 was significantly down-regulated in glioma tissues and cell lines. High level of SIRT1 predicted better prognosis of glioma patients. Rescue experiments confirmed that SIRT1 was responsible for the regulatory role of circ_0005075 in the malignant progression of glioma.
CONCLUSIONS: Circ_0005075 is up-regulated in glioma tissues and correlated with distant metastasis and poor prognosis of glioma patients. Furthermore, it aggravates the malignant progression of glioma by down-regulating SIRT1.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 31957839     DOI: 10.26355/eurrev_202001_19918

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  3 in total

Review 1.  Emerging roles of circular RNAs in neuropathic pain.

Authors:  Derong Xu; Xuexiao Ma; Chong Sun; Jialuo Han; Chuanli Zhou; Matthew T V Chan; William K K Wu
Journal:  Cell Prolif       Date:  2021-10-08       Impact factor: 6.831

2.  Hsa_circ_0072309 enhances autophagy and TMZ sensitivity in glioblastoma.

Authors:  Fanen Yuan; Si Zhang; Qian Sun; Liguo Ye; Yang Xu; Zhou Xu; Gang Deng; Shenqi Zhang; Baohui Liu; Qianxue Chen
Journal:  CNS Neurosci Ther       Date:  2022-02-25       Impact factor: 7.035

3.  Knockdown of circ_0055412 promotes cisplatin sensitivity of glioma cells through modulation of CAPG and Wnt/β-catenin signaling pathway.

Authors:  Qingjiu Zhou; Qiang Fu; Mahati Shaya; Yalikun Kugeluke; Shaoshan Li; Yisireyili Dilimulati
Journal:  CNS Neurosci Ther       Date:  2022-03-25       Impact factor: 7.035

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.